Welcome to our dedicated page for Lucyd SEC filings (Ticker: LUCY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Innovative Eyewear filings document a Nasdaq-listed smart eyewear issuer with common stock under LUCY and warrants under LUCYW. Recent Form 8-K reports cover results of operations, preliminary financial information, operational highlights, executive title and principal financial officer changes, and annual-meeting matters.
The company's regulatory disclosures also record stockholder voting outcomes, director elections, auditor ratification matters, quorum and adjournment mechanics, exhibit filings and Inline XBRL cover-page data. These filings frame the public-company record around governance, capital structure and event-driven disclosures for its smart eyewear business.
Innovative Eyewear Inc. director and 10% owner Vladimir Galkin reported multiple transactions in the company’s common stock. On 12/29/2025, he reported a transaction in 46,107 shares at a price of $1.10 per share, leaving 749,900 shares beneficially owned. On 12/30/2025, he reported 11,303 shares at $1.08 per share, with 738,597 shares beneficially owned afterward. On 12/31/2025, he reported 89,830 shares at $0.99 per share, leaving 648,767 shares beneficially owned. On 01/02/2026, he reported 1,262 shares at $0.97 per share, for a resulting beneficial ownership of 647,505 shares. The filing notes that the reported per share prices include commissions and that the shares are held jointly by Vladimir and Angelica Galkin.
Innovative Eyewear Inc director Vladimir Galkin reported two transactions in the company’s common stock. On 12/10/2025, a transaction labeled code 'P' involved 50,300 shares at $1.49 per share, leaving 947,193 shares beneficially owned directly afterward. On 12/11/2025, another code 'P' transaction covered 8,423 shares at $1.58 per share, with 938,770 shares beneficially owned directly afterward. The filing notes these common shares are held jointly by Vladimir and Angelica Galkin, husband and wife.
Innovative Eyewear Inc reported an insider stock purchase by director Vladimir Galkin. On 12/04/2025, he bought 2,507 shares of common stock at $1.5 per share in an open-market transaction classified as a purchase.
After this trade, Galkin beneficially owns 997,493 shares of Innovative Eyewear common stock. The filing explains that these shares are held jointly by Vladimir Galkin and his wife, Angelica Galkin, reflecting shared ownership within the household.
Innovative Eyewear (LUCY) filed its Q3 2025 10‑Q reporting stronger sales and improved margins. Revenue for the quarter was $668,128, up sharply from $253,599 a year ago, driven by the Lucyd Armor safety line and the Reebok Powered by Lucyd collection. Gross profit rose to $244,837, with gross margin improving to 37% from 23% as sourcing and logistics efficiencies offset tariff pressures. The company reported a net loss of $(1,836,267) versus $(1,720,677) in the prior-year quarter.
Year-to-date revenue reached $1,701,859, with a net loss of $(5,721,064). Cash and cash equivalents were $6,699,515 as of September 30, 2025, supported by cash inflows from warrant exercises, inducement transactions, and at‑the‑market sales. Stockholders’ equity increased to $10,250,218. Management states liquidity is expected to fund operations for at least the next 12 months. A subsequent event adds $570,000 from a legal settlement. As of November 6, 2025, there were 5,350,183 common shares outstanding.
Innovative Eyewear (LUCY) announced executive title changes. Konrad Dabrowski resigned as Co‑Chief Financial Officer and became Chief AI and Growth Officer. Oswald Gayle, previously Co‑Chief Financial Officer, is now Chief Financial Officer and will serve as the company’s principal financial officer.
The Board of Directors approved these changes effective November 1, 2025. The company stated there were no compensation changes for Mr. Dabrowski or Mr. Gayle in connection with the new roles.
Innovative Eyewear, Inc. (LUCY) reported results of its 2025 annual meeting of stockholders. Of 3,574,602 shares entitled to vote, 1,793,176 shares were present or represented by proxy. Stockholders elected Harrison Gross, Kristen McLaughlin, Louis Castro, and Olivia Bartlett as directors. They ratified Cherry Bekaert LLP as independent auditor for the year ending December 31, 2025 (For 1,559,255; Against 164,120; Abstain 69,801).
Stockholders approved a name change from Innovative Eyewear, Inc. to Lucyd, Inc. (For 1,533,867; Against 188,709; Abstain 70,600) and ratified a one-year extension of the Company’s rights plan (For 809,239; Against 17,908; Abstain 56,896; Broker Non-Votes 909,133). A proposal to reinstate the voting rights of certain control shares was not approved (For 206,055; Against 552,591; Abstain 103,858; Broker Non-Votes 930,594).
Innovative Eyewear, Inc. adjourned its annual meeting after a quorum of common stockholders was not present in person or by proxy to transact business.
The meeting was approved for adjournment by all shares represented and entitled to vote on the adjournment and will reconvene on October 24, 2025 at 10:00 a.m. ET on a virtual basis. The reconvened meeting will consider the proposals described in the notice sent to stockholders of record as of June 30, 2025.
Form 144 notice by a person associated with Innovative Eyewear Inc. (ticker LUCY) proposing a sale under Rule 144. The filer lists 759 shares of Common stock to be sold, with an aggregate market value of $1,641.08, against approximately 4,574,600 shares outstanding, and an approximate sale date of 09/24/2025 on NASDAQ. The securities were acquired as an RSU grant on 08/19/2025, with 7,200 RSU units noted and payment listed as cash. The filing also discloses three sales by David Cohen in the past three months totaling 2,985 shares for gross proceeds of $5,983.00. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information and contains signature/attestation language required by the form.
Innovative Eyewear Inc (LUCY) filed a Form 144 to notify a proposed sale of securities. The filer plans to sell 3,730 common shares through Raymond James & Associates on 09/23/2025 on NASDAQ, with an aggregate market value reported as $8,410. The shares were acquired as an RSU grant on 08/19/2025; the filer shows 5,400 RSU shares acquired and payment noted as cash. The issuer reports 4,574,602 shares outstanding. A related sale in the past three months shows Oswald Gayle sold 1,670 shares on 08/19/2025 for gross proceeds of $3,317. Certain contact and issuer address details are not provided in the filing.